eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case glp 1 drugs for parkinson's

A registered dietitian with experience in GLP-1 medications can help you create a personalized meal plan and set realistic protein goals

When you get some understanding of all this I think some of your earlier queries and replies might make more sense

Tirzepatide , the active ingredient in both Mounjaro and Zepbound is currently being evaluated in phase 3 trials for cardiovascular outcomes in diabetes patients, heart failure with preserved ejection fraction, morbidity and mortality in obesity, and obstructive sleep apnea (OSA)

44 With C-terminal curtailing, the insulinotropic activity of exenatide gradually declines